Replimune (REPL) Shares Outstanding (Diluted Average) (2020 - 2025)

Replimune has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $91.9 million for Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $91.9 million, up 19.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.9 million (up 19.14% YoY), and the FY2025 annual result was $80.6 million, up 21.02% from the prior year.
• Shares Outstanding (Diluted Average) came in at $91.9 million for Q4 2025 at Replimune, roughly flat from $91.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $91.9 million in Q4 2025 to a low of $46.2 million in Q1 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $66.4 million (2023), against an average of $66.2 million.
• Across the five-year window, Shares Outstanding (Diluted Average) grew 4.25% in 2024 and soared 32.28% in 2025, its largest moves.
• Replimune's Shares Outstanding (Diluted Average) stood at $52.1 million in 2021, then climbed by 6.74% to $55.6 million in 2022, then climbed by 19.83% to $66.6 million in 2023, then grew by 15.71% to $77.1 million in 2024, then climbed by 19.14% to $91.9 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $91.9 million (Q4 2025), $91.7 million (Q3 2025), and $91.5 million (Q2 2025), per Business Quant data.